Yes! And this too where Glenn says "really, really exciting"
Seems like early detection is the the key additional factor for governments who will want to see clear advantages, over the FIT test, for saving lives.
I also noticed that the FDA has a fast track program for breakthrough devices. (Google for the info on website, paste not working on my app!)
I do think that the length of time the TGA is taking is potentially a positive sign. Colostat is clearly a highly disruptive technology with far reaching implications on many levels, and so they really need to be extremely thorough. Especially judging by the US Medicare report for EPI ProColon that I posted at the start this thread, which is a very detailed analysis, US obviously, but demonstrates the global medical industry approach to these issues, remembering that the aim here is the mass screening market.![]()
- Forums
- ASX - By Stock
- Holiday Research - US competitive landscape and pan-cancer detection
Yes! And this too where Glenn says "really, really exciting"...
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
|
|||||
Last
6.7¢ |
Change
-0.003(4.29%) |
Mkt cap ! $16.65M |
Open | High | Low | Value | Volume |
6.5¢ | 6.7¢ | 6.5¢ | $4.616K | 70.97K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38161 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.7¢ | 34326 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 238342 | 0.065 |
2 | 110864 | 0.064 |
1 | 131025 | 0.063 |
2 | 15000 | 0.062 |
3 | 59180 | 0.061 |
Price($) | Vol. | No. |
---|---|---|
0.065 | 993 | 1 |
0.068 | 1128 | 1 |
0.070 | 86753 | 4 |
0.071 | 150525 | 1 |
0.072 | 2245 | 1 |
Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |